Target intelligence / Profile preview

Pepsin A-4

Molecular classification
Enzyme, Protease, Aspartic protease, Endopeptidase
01

Overview

Pepsin A-4 is one of the isoforms of pepsin, a powerful aspartic endopeptidase enzyme that is predominantly responsible for initial protein digestion in the human stomach.[1][3][5][8][9] Pepsin is secreted as deactivated pepsinogen by gastric chief cells and becomes activated in the acidic (pH 1.5–2.0) environment of gastric juice.[3] Pepsin cleaves peptide bonds within proteins, especially at sites adjacent to aromatic amino acids, yielding smaller peptide fragments for subsequent digestion and absorption in the small intestine.[2][3][9] In the context of disease, pepsin can contribute to tissue injury when present outside the stomach, particularly in conditions with abnormal reflux such as GERD and LPR, where it serves both as a pathogenic factor and a diagnostic biomarker.[1][4] Multiple isoforms (pepsin A-1, A-2, A-3, and A-4) are produced by pepsinogen gene subtypes; these are collectively referred to as “Pepsin A.”[8] There is nothing unique about a therapeutic role for Pepsin A-4 as a target; it is not specifically targeted by any approved drugs, nor is it a current focus for drug development or inhibition outside research settings. The main clinical use is in the context of laboratory diagnostics (salivary pepsin as a biomarker) and as a component of enzyme supplements for certain digestive disorders.[4][6] Note on entry: "Pepsin A-4" refers to a specific isoform within the pepsin family (pepsinogen 4); pepsin itself is an established enzyme, but "Pepsin A-4" is not widely recognized as a distinct therapeutic target entity. Most medical and scientific sources refer to “Pepsin A” or simply “Pepsin.” Therefore, this specific target designation ("Pepsin A-4") may represent an over-specific or under-standardized name in most biomedical databases, and use of the more general “Pepsin A” or “Pepsin” is advised for canonical forms in structured data.[8][4][9]

Other names
Pepsin 4Pepsinogen 4Pepsinogen A4Pepsin APepsinEC 3.4.23.1
02

Mechanism of action

Catalyzes the breakdown of proteins by hydrolyzing peptide bonds, leading to the production of smaller peptides and amino acids[1][2][5] Pepsin inhibitors like pepstatin act by occupying the active site and mimicking substrate interactions[5]

03

Biological functions

Digestion of dietary proteinsHydrolysis of peptide bonds (especially between aromatic amino acids)Defense against ingested pathogens (antimicrobial activity)[8]
04

Disease associations

Gastroesophageal reflux disease (GERD)Laryngopharyngeal reflux (LPR)Other disorders related to protein digestion[1]
05

Safety considerations

Mucosal damage to the esophagus and airways when present outside the stomach (as in GERD/LPR)[1]No significant therapeutic safety concerns in medicine, as it is not a drug target
06

Interacting drugs

None (no therapeutically approved inhibitors or drugs directly targeting Pepsin A-4; enzyme preparations may be used as digestive supplements in pancreatic insufficiency)[4][6]
07

Biomarkers

Salivary pepsin (diagnostic biomarker for laryngopharyngeal reflux [LPR], under evaluation for clinical use)[1][4]

Beyond the preview

Go deeper on Pepsin A-4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pepsin A-4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call